| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.10.23 | AstraZeneca: IMFINZI (durvalumab) plus LYNPARZA (olaparib) reduced the risk of disease progression or death by 45% vs. chemotherapy in advanced or recurrent endometrial cancer | 776 | Business Wire | IMFINZI reduced the risk of disease progression or death by 29% vs. chemotherapy First Phase III trial to demonstrate clinical benefit of immunotherapy plus PARP inhibition in advanced or recurrent... ► Artikel lesen | |
| 21.10.23 | AnHeart Therapeutics' Investigational Medicine Taletrectinib Shrank Tumors in More Than 90 Percent of People With ROS1-Positive Non-Small Cell Lung Cancer Who Were ROS1 TKI Naïve in Global Pivotal TRUST-II Trial | 555 | Business Wire | Taletrectinib also shrank tumors in 57 percent of people with ROS1-positive NSCLC who had previously been treated with a ROS1 TKI in the trial Taletrectinib continues to be generally well tolerated... ► Artikel lesen | |
| 21.10.23 | Aviapartner Extends Footprint Through Joint Venture With South Africa | 513 | Business Wire | Aviapartner, leading Airport Ground Services group in Europe, enters a Joint Venture with Colossal to serve airlines and passengers in South Africa. With this partnership, the Belgium headquartered... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 451 |
| NVIDIA | 293 |
| DEUTSCHE BANK | 292 |
| BAYER | 226 |
| NEL | 206 |
| TESLA | 196 |
| RHEINMETALL | 155 |
| TUI | 153 |
| SUPER MICRO COMPUTER | 152 |
| BYD | 148 |
| THYSSENKRUPP | 132 |
| BASF | 121 |
| COMMERZBANK | 119 |
| PLUG POWER | 111 |
| AIXTRON SE | 109 |
| GALERIA KARSTADT KAUFHOF GMBH | 109 |
| MICROSOFT | 109 |
| AMAZON | 108 |
| INTEL | 102 |
| META PLATFORMS | 99 |
| RWE | 98 |
| ALPHABET | 93 |
| DELIVERY HERO | 92 |
| PAYPAL | 88 |
| VOLKSWAGEN | 82 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
